» Articles » PMID: 32380791

Hsa-miR-20b-5p and Hsa-miR-363-3p Affect Expression of and Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro

Overview
Journal Cells
Publisher MDPI
Date 2020 May 9
PMID 32380791
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy arising from T lymphocyte precursors. We have previously shown by miRNA-seq, that miRNAs from the mir-106a-363 cluster are overexpressed in pediatric T-ALL. In silico analysis indicated their potential involvement in the regulation of apoptosis. Here, we aimed to test the hypothesis on the pro-tumorigenic roles of these miRNAs in T-ALL cells in vitro. We demonstrate, for the first time, that hsa-miR-20b-5p and hsa-miR-363-3p from the mir-106a-363 cluster, when upregulated in T-ALL cells in vitro, protect leukemic cells from apoptosis, enhance proliferation, and contribute to growth advantage. We show, using dual luciferase reporter assays, Ago2-RNA immunoprecipitation, RT-qPCR, and Western blots, that the oncogenic effects of these upregulated miRNAs might, at least in part, be mediated by the downregulation of two important tumor suppressor genes, and , targeted by both miRNAs. Additionally, we demonstrate the cooperative effects of these two miRNAs by simultaneous inhibition of both miRNAs as compared to the inhibition of single miRNAs. We postulate that hsa-miR-20b-5p and hsa-miR-363-3p from the mir-106a-363 cluster might serve as oncomiRs in T-ALL, by contributing to post-transcriptional repression of key tumor suppressors, and .

Citing Articles

Adapted Exosomes for Addressing Chemotherapy-induced Premature Ovarian Insufficiency.

Mousaei Ghasroldasht M, Park H, Ali F, Beckman A, Mohammadi M, Hafner N Stem Cell Rev Rep. 2025; .

PMID: 39921838 DOI: 10.1007/s12015-024-10820-5.


MiR-363-3p induces tamoxifen resistance in breast cancer cells through PTEN modulation.

Liang Y, Shi C, Wang Y, Fan B, Song W, Shen R Sci Rep. 2024; 14(1):32135.

PMID: 39738797 PMC: 11685982. DOI: 10.1038/s41598-024-83938-8.


Construction of an exosome-associated miRNA-mRNA regulatory network and validation of and miR-17-5p as potential biomarkers associated with ovarian cancer.

Chen L, Lai L, Zheng L, Wang Y, Lu H, Chen Y Transl Cancer Res. 2024; 13(2):1052-1067.

PMID: 38482429 PMC: 10928626. DOI: 10.21037/tcr-23-940.


MicroRNA-363-3p inhibits colorectal cancer progression by targeting interferon-induced transmembrane protein 1.

Wang Y, Bai S, Zhang T, Liao C World J Gastrointest Oncol. 2023; 15(9):1556-1566.

PMID: 37746648 PMC: 10514722. DOI: 10.4251/wjgo.v15.i9.1556.


Construction of lncRNA-miRNA-mRNA regulatory network in severe asthmatic bronchial epithelial cells: A bioinformatics study.

Fan M, Song W, Hao Z, Zhang J, Li Y, Fu J Medicine (Baltimore). 2023; 102(35):e34749.

PMID: 37657025 PMC: 10476739. DOI: 10.1097/MD.0000000000034749.


References
1.
Takahashi R, Prieto-Vila M, Kohama I, Ochiya T . Development of miRNA-based therapeutic approaches for cancer patients. Cancer Sci. 2019; 110(4):1140-1147. PMC: 6447849. DOI: 10.1111/cas.13965. View

2.
Landais S, Landry S, Legault P, Rassart E . Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res. 2007; 67(12):5699-707. DOI: 10.1158/0008-5472.CAN-06-4478. View

3.
Gruszka R, Zakrzewska M . The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors. Int J Mol Sci. 2018; 19(3). PMC: 5877740. DOI: 10.3390/ijms19030879. View

4.
Mavrakis K, Van der Meulen J, Wolfe A, Liu X, Mets E, Taghon T . A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet. 2011; 43(7):673-8. PMC: 4121855. DOI: 10.1038/ng.858. View

5.
Pepe F, Balatti V . Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia. J Clin Med. 2020; 9(2). PMC: 7074107. DOI: 10.3390/jcm9020593. View